V oltage-gated sodium channels (VGSCs) are responsible for the upstroke of the cardiac action potential (AP) and are required for impulse propagation in the heart. 1 They are composed of 1 pore-forming α-subunit and 2 nonporeforming β-subunits. 1 Although α-subunits are sufficient for conduction, β-subunits regulate sodium current (I Na ) by modulating kinetics, voltage dependence, and channel cell surface expression. 2 In addition, some VGSC β-subunits regulate potassium currents (I K ) and function as cell adhesion molecules that are substrates for sequential cleavage by BACE-1 (beta-site amyloid precursor protein enzyme 1) and γ-secretase. 2,3 Mutations in the genes encoding β-subunits are implicated in human disease, including cardiac arrhythmia. 2, 4 Mutations in SCN2B, encoding β2, are associated with atrial fibrillation (AF) and Brugada syndrome (BrS) in humans, 5, 6 suggesting that β2 is critical in establishing or maintaining normal cardiac electric activity. β2 is covalently linked to α, including the major cardiac VGSC, Na V 1.5, via disulfide bonds. 7 β2 enhances the trafficking of neuronal VGSC α-subunits to the plasma membrane and modulates the voltage dependence of channel gating. 8, 9 Consistent with the channel trafficking role of β2, Scn2b null neurons have reduced VGSC cell surface expression with no change in total cellular protein levels. 10 Heterologous coexpression of Na V 1.5 with a SCN2B patient mutation linked to arrhythmia resulted in reduced I Na density compared with Na V 1.5 alone, suggesting defective cell surface VGSC trafficking. 5,6 However, the role of β2 in heart has not been explored in vivo. Here, we test the hypothesis that β2 plays critical roles in cardiac excitability via regulation of cell surface VGSC levels and I Na density. We report changes in I Na and, unexpectedly I K , density and ventricular and atrial arrhythmias in Scn2b null mice. These novel results advance our understanding of the physiological and pathophysiological roles of β2 in the heart.
Role of Sodium Channel β2-Subunits in Heart

Methods
Myocyte isolation, electrophysiological recording, quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), Western blot, super-resolution patch clamp, optical mapping, intracardiac recording, and assessment of fibrosis are described in the Data Supplement.
Animals
This study was performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and with approval from the University of Michigan Institutional Animal Care and Use Committee. Male and female Scn2b null and wild-type (WT) mice, 8 congenic on the C57BL/6J background for over 20 generations, were used at ages indicated in each method in the Data Supplement.
Cell Isolation
WT and Scn2b null cardiac myocytes were acutely isolated. 10 
Single-Cell Electrophysiology
Voltage clamp I Na and I K recordings were performed at room temperature. Current clamp recordings were acquired at 37°C. Cells with a diastolic membrane potential more negative than −65 mV were used for analysis.
qRT-PCR
qRT-PCR was performed as described. 11 
Western Blotting
Western blots were performed as described. 11 
Optical Mapping
Ventricular Mapping
Hearts were perfused through the aorta with warm, oxygenated Tyrode solution followed by 7 μM Blebbistatin (Cayman Chemical) 12, 13 and 100 μM Di-4-ANEPPS (Life Technologies) to uncouple excitation-contraction and to stain the heart, respectively. High-resolution optical mapping was performed, imaging at 800 frames per second. Optical movies were recorded at baseline and at progressively shorter cycle lengths.
Atrial Mapping
The atrium was excised, and a camera was positioned to face the posterior walls of both atria. Arrhythmias were induced by applying burst pacing at 66.67 Hz for 5 or 10 s before and after carbachol administration.
Intracardiac Recording
An octapolar catheter (Science) was inserted through the jugular vein and advanced into the right atrium (RA) and ventricle. Programmed electric stimulation was assessed to determine the basal sinus node recovery time, atrial refractory period, atrioventricular nodal effective refractory period, and ventricular refractory period. Arrhythmia inducibility was assessed by the application of 12 to 18 atrial bursts of pacing, before and after intraperitoneal carbachol (50 ng/g) administration. AF was defined as the occurrence of rapid and fragmented atrial electrograms (lack of regular P waves) with irregular AV nodal conduction and ventricular rhythm, all lasting at least 1 s.
Assessment of Fibrosis
Left atrial and RA posterior walls from both sexes and genotypes were collected and analyzed.
Statistics
Statistical significance was evaluated using Mixed Effects Regression analysis to address multiple observations from individual animals, Student t test, Mann-Whitney rank-sum test, or Fisher exact test, as indicated. P<0.05 was considered significant.
Results
Scn2b Deletion Results in Decreased I Na Density in Ventricular Myocytes
We measured whole-cell I Na in acutely isolated ventricular and atrial myocytes. Null ventricular myocytes showed a reduction in total I Na density over a voltage range of −50 mV to −20 mV ( Figure 1A ) and steeper slope (κ) of the activation curve compared with WT, indicating increased sensitivity to changes in voltage ( Figure 1B ). There were no differences in the voltage dependence of activation or inactivation, kinetics of recovery from inactivation, persistent I Na density, or kinetics of steadystate inactivation between genotypes (Table 1) . In contrast to ventricular myocytes, null atrial myocytes showed no changes in I Na or persistent I Na density, voltage dependence of activation, or inactivation between genotypes, suggesting that the role of β2 in heart is region specific (Figure 1C through 1D; Table 2 ). qRT-PCR ( Figure 1E ) and Western blotting ( Figure  1F ) showed no differences in Scn5a mRNA or Na v 1.5 protein
WHAT IS KNOWN
• Voltage-gated sodium channel β2-subunits are cell adhesion molecules expressed in both brain and heart. In neurons, β2-subunits are known to function to chaperone sodium channel pore-forming α-subunits to the plasma membrane. In addition, generation of C-terminal β2 fragments by sequential cleavage of β2-subunits by BACE-1, and γ-secretase has been shown to regulate sodium channel αsubunit gene transcription in neurons.
• Mutations in the gene encoding sodium channel β2subunits, SCN2B, are associated with atrial fibrillation and Brugada syndrome in human patients. However, the function of β2 in heart has not been studied.
WHAT THE STUDY ADDS
• Scn2b deletion results in changes in reduced sodium current density and, unexpectedly, reduced potassium current density in ventricular myocytes, with subsequent slowing of conduction in the right ventricular outflow tract region.
• Slowed conduction and prolonged repolarization in the right ventricular outflow tract interact with premature ventricular complexes to initiate functional reentry, increasing the susceptibility of Scn2b null hearts to ventricular arrhythmia.
• In contrast to the ventricle, atrial sodium current density and biophysical properties are not different between genotypes, demonstrating region-specific functionality of β2 in the heart.
• Scn2b null mice are more susceptible to atrial fibrillation and have increased atrial fibrosis compared with wild type. Increased functional and anatomic heterogeneity in the atrium because of repolarization dispersion and fibrosis may contribute to the mechanism of atrial arrhythmia in Scn2b null hearts.
in the ventricle, respectively, between genotypes, suggesting that changes in I Na density in null ventricle are because of defective VGSC targeting to the plasma membrane, similar to that observed in neurons. 8, 9 VGSCs are differentially localized to subcellular domains in cardiac myocytes. 7, 14 We performed super-resolution scanning patch clamp recordings of I Na at the T-tubules and cell crests of ventricular myocytes 15 to investigate the changes in the subcellular distribution of VGSCs in response to Scn2b deletion. No differences were apparent between genotypes ( Figure I in the Data Supplement), suggesting that, in agreement with immunofluorescence data, 14 I Na in Scn2b null myocytes may be most affected at the intercalated discs. Alternatively, it is possible that channel openings at both sites may be less frequent events in the null myocytes.
Scn2b Null Hearts Have Impaired Impulse Propagation in the Right Ventricular Outflow Tract Region
We performed optical mapping of ex vivo. Langendorff perfused hearts to investigate the effects of Scn2b deletion on cardiac conduction ( Figure 2 ). Slowed conduction was observed in the null right ventricular outflow tract (RVOT), but not in the RV region, compared with WT ( Figure 2A through 2C). To examine excitability changes in this region more closely, we performed current clamp recordings of APs in RVOT myocytes. AP amplitude, maximal upstroke velocity, and resting membrane potential were not statistically different between genotypes (Figure IIA through IIC in the Data Supplement; WT: N=8, n=10-14; Scn2b null: N=5, n=11-16). Action potential durations (APDs) at early phases (APD were unchanged between genotypes (Figure IID through IIF in the Data Supplement). In contrast, late-phase APDs (APD 70-90 ) showed significant prolongation in null myocytes at different pacing frequencies ( Figure 3A through 3C). Consistent with the prolongation of late-phase APD, we observed a significantly higher incidence of early after depolarizations in null myocytes (9/21 cells) compared with WT (1/15 cells; Figure 3C and 3D; P=0.024).
Scn2b Deletion Results in Impaired Steady-State K + Current in Ventricular Myocytes
We recorded I K density from RVOT myocytes to ask whether alterations in repolarizing currents may underlie prolongation of late-phase APD in the nulls ( Figure 3E and 3F). We observed no differences in I K,peak density between genotypes ( Figure 3E ). The decay phase of the current was fit with a biexponential function to assess the contributions of slowly inactivating I K (I K,slow ) and transient outward current (I to ). 16 There were no differences between genotypes for I K,slow or I to density ( Figure 3E ). There were no differences between genotypes in the time constants of inactivation for , with no differences in cell capacitance between genotypes (Scn2b null vs WT: 115.9±13.3, n=9, N=6, vs 85.85±11.8, n=12, N=6; P=0.136, MRE analysis). B, Scn2b deletion had no effect on the voltage dependence of activation (P=0.065, null: n=12, N=6; WT: n=9, N=6, MRE analysis) but decreased the slope factor κ (P=0.005, null: n=12, N=6; WT: n=9, N=6, MRE analysis). C, No change in atrial I Na density between genotypes (P=0.07-0.92 over a voltage range from −100 to 5 mV, null: n=15, N=3; WT: n=12, N=3, MRE analysis). D, Scn2b deletion had no effect on the voltage dependence of activation (P=0.15) or slope factor κ (P=0.56; null: n=15, N=3; WT: n=12, N=3, MRE analysis). E, Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) shows no difference in levels of Scn5a transcript between null and WT ventricle relative to GAPDH controls (null: N=6, WT: N=6, P=0.98, Student t test). F, Western blotting shows no difference in Na v 1.5 protein levels between null and WT ventricle (upper). α-actin was used as a loading control for quantification (lower). (WT: N=4; null: N=4, P=0.63, Student t test.) n indicates number of cells tested; and N, number of animals tested. Role of Sodium Channel β2-Subunits in Heart I K,slow (1404±183 versus 1289±84 ms; P=0.61, not shown) or I to (93.6±29.1 versus 75.06±13.6 ms; P=0.61, not shown) for WT and null, respectively. In contrast, noninactivating steady-state I K (I K,SS ) density was decreased by 40% in null myocytes at 20 and 30 mV ( Figure 3E ). We observed no differences in the inward rectifying current, I K1 , density between genotypes ( Figure 3F ). Prolonged late-phase APD is in agreement with the finding of decreased I K,SS , which determines I K amplitude at times late after the onset of depolarization. 17
Scn2b Null Ventricles Are Arrhythmogenic
To assess the susceptibility of null ventricles to arrhythmia, we performed optical mapping with simultaneous, volumeconducted ECGs in isolated hearts ( Figure 4 ). Episodes of spontaneous, nonsustained ventricular tachycardia were observed in 3 of 10 null hearts, and premature ventricular complexes (PVCs) were observed in 4 of 10 null hearts, but none in the 11 WT hearts tested ( Figure 4A) . Figure 4B and 4C shows anatomic views of the heart during the optical mapping and epicardial activation during a sinus beat, respectively. As expected, 12 during the sinus beat, 2 breakthroughs appeared on the LV and RV free wall close to the apex and the excitation wavefront then propagated toward the base of the heart. All spontaneous aberrant rhythm events appeared with a PVC within an average of 25 to 26 minutes after cannulation and before pacing or administration of drugs ( Figure 4D ). Episodes of spontaneous nonsustained ventricular tachycardia (VT) were recorded, and phase maps were generated to analyze activation patterns during tachycardia ( Figure 4D through 4F). Rotors were observed (Movie I in the Data Supplement), implicating functional reentry as the underlying mechanism of arrhythmia in null hearts. Singularity points, the organizing centers of each rotor, were concentrated in the null RVOT ( Figure 4E ), suggesting that wavebreaks were more likely to occur in this area. Rotors were not confined to the RVOT but observed to meander to the left and right anterior ventricular free walls over time ( Figure 4F ), giving rise to the polymorphic appearance of the ECG ( Figure 4D ). Closely coupled PVCs served as triggers for nonsustained ventricular tachycardia initiation in null hearts. Chronological snapshots taken from a phase movie of a null heart, capturing initiation of an episode of spontaneous polymorphic VT, illustrate the interplay between a PVC and the arrhythmogenic substrate leading to arrhythmia ( Figure Data are expressed as mean (95% confidence interval). Kinetics of inactivation were recorded at a test potential of −45 mV. Persistent I Na was recorded at a test potential −45 mV, 50 to 52 ms after the voltage step. n indicates number of cells tested; N, number of animals tested; and WT, wild type. *Significance determined by Mixed Effects Regression analysis with P<0.05. Data are expressed as mean (95% confidence interval). P values were determined with Mixed Effects Regression analysis or Student t test (for mV of peak I Na ) with P<0.05. Kinetics of inactivation were recorded at a test potential of −45 mV. Persistent I Na density was recorded at a test potential −45 mV, 50 to 52 ms after the voltage step. n indicates number of cells tested; N, number of animals tested; pA/pF, pico-amps per pico-farad; and WT, wild type. 
Scn2b Null Mice Have a Normal Cardiac Conduction System
We performed intracardiac recordings to measure the conduction time for each segment along the conduction pathway and to assess the electrophysiological properties of the sinoatrial node and atrioventricular node. Atrial-His conduction time, His-ventricular conduction time, sinoatrial node recovery time, atrioventricular node refractoriness, and Wenckebach periodicity were similar between genotypes ( Table 3 ), suggesting that the conduction system is intact in Scn2b null hearts.
Scn2b Null Mice Have Increased Susceptibility to AF In Vivo
AF can be reproducibly induced in the mouse heart by a combination of endocardial pacing and administration of the cholinergic agonist, carbachol. [18] [19] [20] We applied burst pacing before and after carbachol administration to test whether null hearts are prone to atrial arrhythmias. The efficacy of carbachol was assessed by the observation of decreased heart rate after drug administration. We defined AF as episodes of 1 s or longer in duration, before or after carbachol administration, during burst pacing or the S1-S2 protocol, in which the heart is paced with a train of pulses (S1) followed by a premature stimulus (S2). Using these criteria, we found that AF susceptibility was higher in null (7/9) compared with WT (1/7; P=0.02, Figure 5A ). Durations of induced AF were variable in null mice, ranging from just over 1 s to 11 minutes (Figure 5B) . In contrast, the majority of AF episodes in WT mice had durations of <1 s (not shown). Figure 5C shows a representative surface ECG lead-II trace and atrial electrogram acquired during AF/AT in a null mouse. This is compared with traces from a WT mouse that was resistant to induction of tachyarrhythmia.
Reentry Underlies the Mechanism of AF in Scn2b Null Atria
To investigate the mechanism of atrial arrhythmia in null hearts, we performed ex vivo optical mapping ( Figure 6A ). Consistent with in vivo observations, we induced AF by burst pacing in 5 of 11 null atria compared with 1 of 10 WT atria in the absence of carbachol (P=0.073). As expected from previous work, [18] [19] [20] carbachol administration increased the level of AF induction in both genotypes (6/11 Scn2b null versus 3/10 WT, P=0.39). Phase movies recorded during AF in null atria showed variable forms of rotors, which served as drivers to maintain the arrhythmia. Figure 6B and Movie II in the Data Supplement demonstrate AF driven by a single rotor in the RA. Figure 6C and Movies III and IV in the Data Supplement show AF driven by 2 rotors in the figure-of-eight conformation (2 counterclockwise rotating rotors that share a common pathway) in the RA in the absence of carbachol and then driven by a single rotor in the pulmonary vein region of the left atria after carbachol administration. Figure 6D and Movie V in the Data Supplement show AF driven by 3 independent rotors at different dominant frequencies (17.7 and 26.5 Hz, respectively). One rotor was located in the RA, whereas the other 2, with figure-of-eight configuration at the higher common frequency, were located in the pulmonary vein region. In this case, the AF terminated and then was spontaneously reinitiated by a sinus beat because of wavebreak in the RA. This reinitiated AF was sustained by a single rotor in the RA ( Figure 6D ). Spontaneous AF was also observed in 1 null atrium but not in any of the WT atria, suggesting higher atrial arrhythmogenicity in the mutant animals ( Figure IV in the Data Supplement). Taken together, the dynamic, complex, and nonhierarchical organization of rotors in Scn2b null atria suggests that the substrates for AF/AT may be functionally and anatomically heterogeneous.
APD Is Heterogeneously Prolonged in Scn2b Null Atrium
In contrast to the RVOT, we observed no changes in atrial conduction velocity between genotypes (Figure V in the Values are means±SE. P values were determined using Student t test and Mann-Whitney rank-sum test. AERP indicates right atrial effective refractory period; AH, interval from atrial to His-signal; AVERP, atrial-ventricular effective refractory period; HV, interval from His to first QRS movement in surface ECG; N, number of mice; SNRT, sinus node recovery time; VERP, right ventricular effective refractory period; WP, Wenckebach periodicity; and WP 2:1 , Wenckebach periodicity at 2:1 conduction. Subscripts indicate S1S1 drive cycle lengths.
Figure 4
Continued. propagated toward the base of the heart. White lines: isochrone lines in ms. D, Volume-conducted ECG (bipolar mode, frontal plane) showed 3 episodes of polymorphic nonsustained ventricular tachycardia (NSVT) and PVC. Each episode of VT was triggered by a PVC, sharing the same morphology as a single independent PVC, indicating a focal source of the triggering ectopic beat. The polymorphic VT had a frequency transition from 24.7 to 20.8 Hz. E, Singularity point map showing that the location of the rotors (white dots) remained in the right ventricular outflow tract (RVOT) during most of the recording period. F, Phase map snapshots of 2 rotors during VT. Rotors are dynamic, spin in multiple directions, and meander to other regions, giving rise to the polymorphic appearance of ECG. RCA indicates right coronary artery. Role of Sodium Channel β2-Subunits in Heart Data Supplement). AP recordings from single RA myocytes showed no differences in amplitude, maximum upstroke velocity, or resting membrane potential between groups (Figure 7A) . We observed a significant increase in the later phases of the APD (APD 50-90 ) in null myocytes compared with WT at the highest pacing frequency tested ( Figure 7B ). Figure 7C shows representative, superimposed AP waveforms from each genotype to illustrate the AP prolongation in null atrial myocytes compared with WT. In Figure 7D , we plot the range of APD values for atrial myocytes of each genotype to illustrate the degree of heterogeneity in the null atrial data set. For comparison, Figure VI in the Data Supplement shows the range of APD values for ventricular myocytes of each genotype. We propose that this dispersion of repolarization in atrial myocytes generates functionally heterogeneous substrates in the null atrium that predispose the tissue to wavebreak during fast pacing.
Increased Fibrosis in Scn2b Null Right Atrium
Evidence connects cardiac VGSC dysfunction to fibrosis. [21] [22] [23] To assess the presence of fibrosis in the null model, the posterior walls of the RA and left atria were sectioned in the coronary plane parallel to the posterior wall and stained using Masson trichrome protocol. We observed increased levels of fibrosis in the null RA, but not the left atria, compared with WT ( Figure 8A and 8B) . We propose that fibrotic tissue deposited in the null RA interstitial space creates anatomic substrates for wavebreaks and anchor points for rotors and may explain transitions from AF to atrial flutter in the null animals (eg, Figure 8C ).
Discussion
This study presents the first investigation of the effects of Scn2b deletion on cardiac electrophysiology in mice. Loss of VGSC β2 results in reduction of I Na density because of Figure 5 . Scn2b null atria are more susceptible to atrial fibrillation (AF). AF was defined as episodes of >1 s either before or after carbachol administration. Animals that had at least 1 AF episode that lasted >1 s were considered to be inducible. A, Null mice (7/9) were more susceptible to atrial arrhythmia than wild type (WT; 1/7) (P=0.02, Fisher exact test, 1-tailed). B, Distribution of the durations of all AF episodes recorded in nulls. The majority of episodes recorded in WT were <1 s (not shown). C, Representative surface ECG and atrial electrogram from each group. Under 5-s 50 Hz burst pacing with carbachol administration, AF/AT could be induced in nulls but not in WT. During AF, the atrial electrogram was more disorganized. Numbers on the bars indicate number of animals tested. Role of Sodium Channel β2-Subunits in Heart impaired channel cell surface expression over a defined voltage range and reduction of I K,SS density in ventricular myocytes, with subsequent slowing of conduction in the RVOT. Slowed conduction and prolonged repolarization in the RVOT interact with PVCs to initiate functional reentry, increasing the susceptibility of null hearts to ventricular arrhythmia. In contrast to the ventricle, atrial I Na density and biophysical properties were not different between genotypes, demonstrating region-specific functionality of β2 in the heart. Finally, null mice are more susceptible to AF/AT and have increased atrial fibrosis compared with WT. We propose that increased functional and anatomic heterogeneity in the atrium because of repolarization dispersion and fibrosis contribute to the mechanism of atrial arrhythmia in Scn2b null hearts.
Scn2b Null Mice May Mimic Some Aspects of BrS
BrS is a rare cardiac disease that results in increased risk of ventricular fibrillation and sudden cardiac death. 24 Approximately 35% of BrS cases are attributable to known pathogenic gene variants, with ≈30% of these resulting from loss of I Na . 25 The RVOT is the most affected region in human heart in BrS. 26 Similarly, Scn2b null mice have reduced I Na density throughout the ventricle with decreased impulse propagation in the RVOT. Although the mechanism for selective propagation slowing in the RVOT here and in human BrS is not completely understood, previous work has shown that Scn5a mRNA and Na v 1.5 protein levels are reduced in the WT mouse RVOT compared with the rest of the RV. 27 This normally occurring lowered conduction reserve is proposed to result in greater conduction slowing in the RVOT under conditions of reduced cardiac I Na , for example, administration of VGSC blocking agents or the presence of loss-of-function VGSC gene mutations, increasing the susceptibility for arrhythmias. We propose that reductions in functional VGSC expression in Scn2b null ventricle result in larger decrements in conduction reserve in the RVOT compared with the remainder of the RV. In addition to aberrant depolarization, prolongation of repolarization is observed in the RVOT of BrS patients. 26, 28, 29 We observed reduced I K,SS density and prolongation of the APD in Scn2b null RVOT myocytes, results that are functionally consistent with clinical findings.
PVCs and Arrhythmogenesis in Scn2b Null Hearts
PVCs are proposed to serve as triggers for arrhythmogenesis. Trigger elimination, by focal ablation of PVCs originating from the RVOT, 30 is effective in preventing arrhythmic events in patients. The timing of emergence and spatial orientation of the excitation wavefronts of ectopic beats are key factors in arrhythmia initiation. In Scn5a +/− mice, PVCs play important roles in initiating reentrant, spontaneous polymorphic VT. 31 In Scn2b null hearts, every recorded VT episode occurred after a PVC, suggesting a requirement for PVCs to serve as triggers. In addition, epicardial breakthrough of the initiating PVC was observed at the RV free wall near the apex rather than at the RVOT. We found no differences in the coupling interval between VT-initiating PVCs and PVCs that did not trigger VT ( Figure VII in the Data Supplement). Because the morphologies of these PVC types were similar, we propose that the origins of the PVCs were focal. Thus, the subsequent occurrence of VT was dependent on the repolarizing state of the preceding sinus beat, in which case the repolarization or refractoriness was dynamic.
SCN2B and AF
AF is the most prevalent clinical arrhythmia, 32 with even higher incidence in BrS compared with the general population. 28, 29, [33] [34] [35] Both loss-and gain-of-function mutations in SCN5A have been linked to familial AF. 36 The 2 reported AF patients with SCN2B mutations exhibited saddleback-type ST-segment elevation in the right precordial leads, suggesting that these individuals may have also experienced BrS-like symptoms. 6 Here, Scn2b deletion resulted in effects on atrial AP repolarization and tissue remodeling, but not atrial I Na . The APD was increased in a heterogeneous fashion in Scn2b null atrium, resulting in larger repolarization dispersion. In addition, higher levels of fibrosis were found preferentially in Scn2b null RA. These changes are proposed to provide electric and anatomic substrates that favor AF. The notion of increased heterogeneity of Scn2b null atrium is supported by our finding that the number, frequency, location, and organization of rotors are highly dynamic and complex.
Increased fibrosis in Scn2b null atrium is consistent with reported links between VGSC dysfunction and fibrosis in the heart. For example, transforming growth factor -β1-mediated fibrosis is triggered by Scn5a disruption. 21 In other studies, relaxin suppressed AF in aged rats 37 and in spontaneously hypertensive rats 38 through decreased atrial fibrosis, increased I Na , and increased atrial conduction velocity. As an alternative hypothesis, fibrosis in null mice may be triggered directly by the absence of β2 polypeptides during atrial development. β2-subunits are substrates for sequential cleavage by BACE-1 and γ-secretase. 39 The cleaved intracellular domain of β2, at least in neurons, translocates to the nucleus to participate in transcriptional regulation of VGSC α-subunits and possibly other genes. 39 Thus, the cleaved β2 intracellular domain may normally regulate genes that inhibit fibrosis in the atrium, resulting in uncontrolled fibrosis in Scn2b null hearts.
In summary, Scn2b null mice may be useful for modeling aspects of human ventricular arrhythmias that exhibit increased susceptibility to atrial arrhythmia. This study provides insight into the role of VGSC β2-subunits in maintaining normal cardiac electric activity and provides a novel perspective on the connection between ventricular and atrial arrhythmias in patients who carry VGSC gene mutations.
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